Launching into the new reality: How COVID-19 is reshaping medtech’s launch strategy

Posted by ZS Editors on May 26, 2020

Access COVID-19 resources

Innovation continues to excite people, even though the global pandemic has ground business as usual to a halt. As COVID-19 continues to reshape the healthcare market, many medtech companies are debating whether to launch and how to drive launch excellence in this new market reality full of changes and uncertainties.  


>
Read More

Road to recovery: What COVID-19 means for medtech in China and around the world

Posted by Tim Lee on May 4, 2020

Access COVID-19 resources

Given the increasing toll that COVID-19 lockdowns are imposing on economies, many markets that have seen their peaks are beginning preparations to reopen. As the first market impacted by COVID-19 and the first to institute a gradual reopening since March, China is two months ahead of all other major markets in their recovery journey. We spoke to several medtech executives across different spaces to get a glimpse of what the future may look like in China, as well what it may mean for other markets.


>
Read More

How COVID-19 will remake healthcare in the Western world

Posted by Brian Chapman on April 27, 2020

Access COVID-19 resources

Locked in our homes and nervously refreshing the Johns Hopkins website to see the latest numbers on the global pandemic, we are living in truly historic times. Some of us are worried about ourselves and our loved ones. Others are worried about employment, or their freedom, choices and the vibrant economy they forgot to enjoy. As we stay inside, now our houses are too small and our spouses too close, and our bored children are slowly atrophying from the lack of sun, friends and stimulation. Only the dogs are happy with this situation.


>
Read More

Expediting the return to work: Testing for active virus and antibodies

Posted by Ben Hohn on April 15, 2020

This blog post was co-written by Jim Adelizzi with contributions from Vidhyasagari Sundaram and Soumya Tayal.

Access COVID-19 resources

With molecular testing capacity to identify people with active virus ramping up quickly (increasing 100-fold since March 10th) and blood tests anticipated for antibody testing on the horizon, multiple government officials are now indicating that testing may allow some to return to work in May or June. Moreover, broader population testing may allow more effective and selective quarantining. There’s increasing reason to believe that "silent" COVID-19 cases—those who are infected but have not experienced symptoms, or those who have recovered from mild symptoms and were never tested—are significant.


>
Read More

Finding Purpose: The Role of the Sales Force During COVID-19

Posted by Chris Morgan on April 9, 2020

Emily Alexander and Jason Brown co-wrote this blog post with Chris Morgan. 

Access COVID-19 resources

The most pressing challenge for our society is the impact the COVID-19 pandemic is having on the global population and economy. Protecting the health of the population is the chief priority, and stabilizing the economy is the next most urgent. However, as medtech companies navigate this challenging landscape, leadership also is grappling with how to keep their sales teams engaged and productive. Medtech companies are rapidly addressing practical issues like incentives, targets and rewards and are accelerating initiatives in digital communication and virtual learning.


>
Read More